125 related articles for article (PubMed ID: 34323956)
1. Cytoplasmic EBP50 and elevated PARP1 are unfavorable prognostic factors in ovarian clear cell carcinoma.
Matsumoto T; Yoki A; Konno R; Oguri Y; Hashimura M; Tochimoto M; Nakagawa M; Jiang Z; Ishibashi Y; Ito T; Kodera Y; Saegusa M
Carcinogenesis; 2021 Oct; 42(9):1162-1170. PubMed ID: 34323956
[TBL] [Abstract][Full Text] [Related]
2. Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma.
Nakagawa M; Matsumoto T; Yokoi A; Hashimura M; Oguri Y; Konno R; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Kodera Y; Saegusa M
Mol Oncol; 2023 Oct; 17(10):2168-2182. PubMed ID: 37539980
[TBL] [Abstract][Full Text] [Related]
3. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
[TBL] [Abstract][Full Text] [Related]
4. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.
Lin YY; Hsu YH; Huang HY; Shann YJ; Huang CY; Wei SC; Chen CL; Jou TS
J Clin Invest; 2012 May; 122(5):1881-94. PubMed ID: 22466651
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadherin pathway in human hepatocellular cancer.
Peng XL; Ji MY; Yang ZR; Song J; Dong WG
World J Gastroenterol; 2013 Feb; 19(8):1306-13. PubMed ID: 23483729
[TBL] [Abstract][Full Text] [Related]
6. Ezrin-Radixin-Moesin Binding Phosphoprotein 50: A Potential Novel Biomarker in Human Papilloma Virus-Associated Head and Neck Squamous Cell Carcinomas.
Shankar A; Crouch DH; Macluskey M
Head Neck Pathol; 2019 Jun; 13(2):188-197. PubMed ID: 29846905
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of targeting drug-based molecular biomarkers expression in ovarian clear cell carcinoma].
Li MJ; Li HR; Cheng X; Bi R; Tu XY; Liu F; Chen LH
Zhonghua Fu Chan Ke Za Zhi; 2017 Dec; 52(12):835-843. PubMed ID: 29325268
[No Abstract] [Full Text] [Related]
8. Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.
Ota Y; Koizume S; Nakamura Y; Yoshihara M; Takahashi T; Sato S; Myoba S; Ohtake N; Kato H; Yokose T; Miyagi E; Miyagi Y
Oncol Rep; 2021 Mar; 45(3):1023-1032. PubMed ID: 33650653
[TBL] [Abstract][Full Text] [Related]
9. p53 and ANXA4/NF‑κB p50 complexes regulate cell proliferation, apoptosis and tumor progression in ovarian clear cell carcinoma.
Liu J; Wang H; Zheng M; Deng L; Zhang X; Lin B
Int J Mol Med; 2020 Dec; 46(6):2102-2114. PubMed ID: 33125094
[TBL] [Abstract][Full Text] [Related]
10. Nuclear expression of NHERF1/EBP50 in Clear Cell Renal Cell Carcinoma.
Lema BE; Patricio GM; Kreimann EL
Acta Histochem; 2021 Jul; 123(5):151717. PubMed ID: 33965858
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
Song J; Bai J; Yang W; Gabrielson EW; Chan DW; Zhang Z
Histopathology; 2007 Jul; 51(1):40-53. PubMed ID: 17593079
[TBL] [Abstract][Full Text] [Related]
12. Let-7e Suppresses DNA Damage Repair and Sensitizes Ovarian Cancer to Cisplatin through Targeting PARP1.
Xiao M; Guo J; Xie L; Yang C; Gong L; Wang Z; Cai J
Mol Cancer Res; 2020 Mar; 18(3):436-447. PubMed ID: 31722968
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) by Akt promotes stability and mitogenic function of S-phase kinase-associated protein-2 (Skp2).
Song GJ; Leslie KL; Barrick S; Mamonova T; Fitzpatrick JM; Drombosky KW; Peyser N; Wang B; Pellegrini M; Bauer PM; Friedman PA; Mierke DF; Bisello A
J Biol Chem; 2015 Jan; 290(5):2879-87. PubMed ID: 25492869
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of RALYL suppresses the progression of ovarian clear cell carcinoma through inhibiting MAPK and CDH1 signaling pathways.
Xia Y; Ye S; Yang Y; Liu Y; Tong G
Int J Med Sci; 2021; 18(3):785-791. PubMed ID: 33437214
[No Abstract] [Full Text] [Related]
15. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation.
Oh YS; Heo K; Kim EK; Jang JH; Bae SS; Park JB; Kim YH; Song M; Kim SR; Ryu SH; Kim IH; Suh PG
Exp Mol Med; 2017 Jul; 49(7):e351. PubMed ID: 28684865
[TBL] [Abstract][Full Text] [Related]
16. A regulated complex of the scaffolding proteins PDZK1 and EBP50 with ezrin contribute to microvillar organization.
LaLonde DP; Garbett D; Bretscher A
Mol Biol Cell; 2010 May; 21(9):1519-29. PubMed ID: 20237154
[TBL] [Abstract][Full Text] [Related]
17. Identification of EBP50 as a specific biomarker for carcinogens via the analysis of mouse lymphoma cellular proteome.
Lee YJ; Choi IK; Sheen YY; Park SN; Kwon HJ
Mol Cells; 2012 Mar; 33(3):309-16. PubMed ID: 22434383
[TBL] [Abstract][Full Text] [Related]
18. Reduced EBP50 expression or mis-localization of the EBP50 protein is associated with the malignant progression of esophageal squamous cell carcinoma.
Wang L; Du YR; Ji MY; Wang W; Zhan N; Zhou QS; Dong WG
Eur Rev Med Pharmacol Sci; 2014; 18(24):3854-63. PubMed ID: 25555876
[TBL] [Abstract][Full Text] [Related]
19. EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.
Li H; Zhang B; Liu Y; Yin C
Med Oncol; 2014 Sep; 31(9):162. PubMed ID: 25119502
[TBL] [Abstract][Full Text] [Related]
20. An immature inhibin-α-expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis.
Kusumoto S; Kurashige M; Ohshima K; Tahara S; Matsui T; Nojima S; Hattori S; Morii E
Cancer Med; 2021 Mar; 10(5):1485-1500. PubMed ID: 33611864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
